Mainstream

United Therapeutics outlines $1B share repurchase and 12% revenue growth while advancing TETON 2 data catalyst

United Therapeutics outlines $1B share repurchase and 12% revenue growth while advancing TETON 2 data catalyst

Post ContentuthrRead More

You might also be interested in reading Exness Team Pro welcomes African trader Nathan Halaba.

July 31, 2025
In Mainstream